Endogenous neutralizing antibodies against platelet-derived growth factor-aa inhibit atherogenesis in the cholesterol-fed rabbit.
Previous studies have shown that the B chain of platelet-derived growth factor (PDGF) has an important role in atherogenesis. In this study we have investigated the contribution of PDGF-A chain in cholesterol-induced atherogenesis in the New Zealand White rabbit. High titers of antibodies to PDGF-AA or to platelet cytosolic protein (PCP) were induced in these animals by immunization against recombinant human PDGF-AA or human PCP. Rabbits were then fed a 0.25% to 1% cholesterol-containing diet for 10 weeks to induce atherosclerotic lesions; the rabbits were then humanely killed and perfusion-fixed and their aortas were removed. The extent of atherosclerosis in the thoracic aortas was determined by quantitative morphometry after staining with oil red O. The intimal and medial areas in histological sections taken at the level of the first intercostal branch were quantified by image analysis. Immunization against PDGF-AA and PCP, but not against adjuvant alone, resulted in rising titers of antibodies within 2 weeks, the levels of which reached a plateau by 8 weeks. The antibodies to PDGF-AA were isoform-specific, recognized both human and rabbit PDGF-AA, and neutralized the biological activity of PDGF-AA in vitro. Integrated plasma cholesterol levels were similar in both groups. Compared with nonimmune rabbits (n=10), animals immunized against PDGF-AA (n=10) or PCP (n=10) had significantly smaller areas of the aorta covered by atherosclerotic lesions (24.6+/-5.1% and 18.7+/-4.2%, respectively, vs 34.4+/-4.3%; P<0.05). This was associated with a reduced aortic intimal-medial area ratio in PDGF-AA-immunized (0.009+/-0.006) and PCP-immunized (0.025+/-0.017) rabbits than in nonimmune animals (0.159+/-0.066; P<0.05). These data suggest that PDGF-AA is actively involved in cholesterol-induced atherosclerosis in the rabbit.
Lamb
D J
DJ
Centre for Clinical Science and Measurement, School of Biological Sciences, University of Surrey, UK.
Avades
T Y
TY
Ferns
G A
GA
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use*; D001011:Aorta / Q000473:pathology; D001161:Arteriosclerosis / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D001792:Blood Platelets / Q000502:physiology; D002784:Cholesterol / Q000008:administration & dosage* / Q000097:blood; D004032:Diet; D006801:Humans; D016233:Immunotherapy, Active; D009500:Neutralization Tests; D010982:Platelet-Derived Growth Factor / Q000276:immunology* / Q000502:physiology; D011817:Rabbits
D000906:Antibodies; D010982:Platelet-Derived Growth Factor; C075278:platelet-derived growth factor A; D002784:Cholesterol